Please save the date for the next Cancer Research UK Convergence Science Centre Symposium, which will take place in-person at the Royal Geographical Society, SW7 2AR.
Welcome into our world of Convergence: an opportunity to be at the forefront of collaborative innovation at the interface of biological and physical sciences: “Engineering Cancer Research”.
We invite you to join our annual symposium where engineering and cancer research converge, creating a unique platform for researcher to engage with the future of biomedical research.
Programme:
Our upcoming symposium will be a celebration of technology's transformative power, echoing the remarkable career of our keynote speaker, Professor Mehmet Toner, a renowned Bioengineer from Harvard Medical School and Massachusetts General Hospital. Professor
Toner's remarkable contributions to biomedical sciences span bio-sensing, regenerative medicine, and tissue engineering. He played a pivotal role in developing cutting-edge microdevices for point-of-care diagnostics, addressing conditions such as
cancer, AIDS, genetic defects, and infectious diseases.
11:00 – 12:00 Enhancing EDI in Research: Elevating Participation and Methodology in Cancer Research and Engineering Innovations
Panel and advisers: Dr Patrick Kierkegaard (CSC), Ms Kelly Gleason (Imperial), Dr Markella Boudioni (RMH), Mr Masood Moghul (RMH, ICR), Ms Georgiana Synesi (ICR), patient representatives.
This session will explore the critical role of Patient and Public Involvement (PPI) in research, with a special emphasis on Equity, Diversity, and Inclusion (EDI). Our panel will offer insights from a researcher’s perspective, complemented by the invaluable views of patient representatives. We are excited to open this evolving discussion to a broader audience. Don't miss this opportunity to engage in a vital conversation about bridging gaps and fostering equality in research methodologies and practices. Come, be a part of this transformative dialogue at the crossroads of cancer research and engineering innovation.
Please note that lunch will not be provided.
13:00 Welcome by Professor Axel Behrens
13:15 Session 1: Convergence of Cancer Biology and Engineering – chaired by Professor Kristian Helin, CEO & President of the ICR
Professor Rylie Green – Head of the Bioengineering Department at Imperial College London
Professor Udai Banerji – Co-Director of the Drug Development Unit (The ICR –Royal Marsden)
Dr Paul Huang – Deputy Director of the Joint Royal Marsden-ICR Sarcoma Research Centre
Professor Yan Yan Sheri Huang – CRUK Cambridge Centre, Department of Bioengineering, University of Cambridge
14:35 Patient and Public Involvement with Kelly Gleason
14:50 TEA BREAK & Poster Session
15:50 Convergence Science Centre Student Short Talks
Melanie Herpels - The ICR & Bioengineering Department at Imperial College London
Melina Beykou - The ICR & EEE Department at Imperial College London
16:20 Session 2: Engineering in medical interventions and imaging – Chaired by Professor George Hanna, Head of the Department of Surgery & Cancer at Imperial
Professor Dow-Mu Koh – Co-Director AI imaging Hub at The Royal Marsden NIHR BRC
Professor Sadaf Ghaem-Maghami – Department of Surgery & Cancer at Imperial College London
Professor Constantin Coussios – Director of the Oxford Institute of Biomedical Engineering, University of Oxford
17:20 Professor the Lord Ara Darzi – Co-Director of the Institute of Global Health Innovation at Imperial College London and co-founder of the CRUK Convergence Science Centre
17:40 Keynote address: Professor Mehmet Toner – Professor of Surgery at Massachusetts General Hospital and Harvard Medical School
18:20 Drinks and networking
NB: Availability of tickets for external academics within the CRUK network will be on a first-come, first-served basis.
